SUSAN PAPARAZO: Open Payments
NPI 1609974468 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 39 payments from 15 companies in 2025. Trend: 2023 $1,141 · 2024 $574 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $193 |
| AstraZeneca Pharmaceuticals LP | 7 | $180 |
| Lilly USA, LLC | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $34 |
| ViiV Healthcare Company | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
Products named: VRAYLAR, FARXIGA, MOUNJARO, UBRELVY, BREZTRI, Auvelity, Rybelsus, APRETUDE.
Industry payments across NC — which companies pay providers there.
